Evidence map›Paper›PMID 30588174›Full record

ArticleCentral-European journal of immunology2018

Serum adiponectin as a predictor of laboratory response to anti-TNF-α therapy in rheumatoid arthritis.

Dorota Sikorska, Rafał Rutkowski, Joanna Łuczak, Włodzimierz Samborski, Janusz Witowski

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Central-European journal of immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Adiponectin Deregulation in Systemic Autoimmune Rheumatic Diseases.International journal of molecular sciences · 2021
    Review
  4. The Adipokine Network in Rheumatic Joint Diseases.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dorota SikorskaDepartment of Rheumatology and Rehabilitation, Poznan University of Medical Sciences, Poznan, Poland.
Rafał RutkowskiDepartment of Pathophysiology, Poznan University of Medical Sciences, Poznan, Poland.
Joanna ŁuczakDepartment of Pathophysiology, Poznan University of Medical Sciences, Poznan, Poland.
Włodzimierz SamborskiDepartment of Rheumatology and Rehabilitation, Poznan University of Medical Sciences, Poznan, Poland.
Janusz WitowskiDepartment of Pathophysiology, Poznan University of Medical Sciences, Poznan, Poland.
Poznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWhile adiponectin is typically viewed as an anti-inflammatory mediator, such an activity of adiponectin in rheumatoid arthritis (RA) is not so obvious. In the present study we examined whether serum levels of adiponectin reflect the clinical phenotype of RA patients and/or correlate with severity of the disease and the response to anti-TNF- MATERIAL AND

methodsTwenty-one female RA patients qualified to receive anti-TNF-

resultsAnti-TNF-

conclusionsIt is possible that adiponectin exerts systemic anti-inflammatory effects independently of the local activity of RA.

Indexed as

adipocytokinesadiponectinanti-TNF-α treatmentinflammationrheumatoid arthritis

Identifiers

PMID30588174
PMCPMC6305609
OpenAlexW2903235635

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.